SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
Authors:
Preprint
Abstract
SUMMARY: Continuous emergence of SARS-CoV-2 variants of concern (VOC) is fueling the COVID-19 pandemic. Omicron (B.1.1.529), is rapidly spreading worldwide. The large number of mutations in its Spike raised concerns about a major antigenic drift that could significantly decrease vaccine efficacy and infection-induced immunity. A long interval between BNT162b2 mRNA doses was shown to elicit antibodies that efficiently recognize Spikes from different VOCs. Here we evaluated the recognition of Omicron Spike by plasma from a cohort of SARS-CoV-2 naïve and previously-infected individuals that received their BNT162b2 mRNA vaccine 16-weeks apart. Omicron Spike was recognized less efficiently than D614G, Alpha, Beta, Gamma and Delta Spikes. We compared to plasma activity from participants receiving a short (4-weeks) interval regimen. Plasma from individuals of the long interval cohort recognized and neutralized better the Omicron Spike compared to those that received a short interval. Whether this difference confers any clinical benefit against Omicron remains unknown.Keywords
All Related Versions
- Published version: Cell Reports, 38 (9), 110429.
This publication has 39 references indexed in Scilit:
- Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UKJournal of Infection, 2021
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyScience, 2021
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Science, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantseLife, 2020
- Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent IndividualsmBio, 2020
- Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 SpikeCell Reports Medicine, 2020
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodiesScience, 2020
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020